论文部分内容阅读
目的:探析在常规治疗方法上加用雾化吸入沙丁胺醇和布地奈德治疗小儿哮喘性支气管肺炎的重要应用价值。方法:本次实验我们选取的实验对象为我院2011年4月1日至2013年4月1日收治的107例小儿哮喘性支气管炎患者。将此107例哮喘性支气管炎患儿的临床资料进行回顾性分析。所有患者按照用药方法不同分为实验组和对照组。实验组55例在常规治疗的基础上加用沙丁胺醇和布地奈德。对照组52例只应用了常规治疗。对比观察两组哮喘性支气管炎患儿的治疗效果、临床症状(咳嗽、气促、肺部啰音)消失时间、不良反应发生率等情况,来具体探析在常规治疗方法上加用雾化吸入沙丁胺醇和布地奈德治疗小儿哮喘性支气管肺炎优势。结果:在常规方法上加用雾化吸入布地奈德、沙丁胺醇的实验组的治疗有效率为,而对照组为,两组相比有显著差异(P<0.05)。实验组各项临床特征的消失时间明显少于对照组(P<0.05)。且实验组小儿哮喘性支气管炎的不良反应率,明显低于对照组(P<0.05)。结论:沙丁胺醇和布地奈德行雾化吸入辅助治疗小儿哮喘性支气管炎,显著提高治疗有效率,加快咳嗽、气促、肺部啰音等症状消失,且没有显著增加不良反应率,值得临床大力推广使用。
OBJECTIVE: To explore the important value of adding inhaled salbutamol and budesonide to asthmatic bronchopneumonia in children with conventional therapy. Methods: This experiment we selected the experimental subjects for our hospital from April 1, 2011 to April 1, 2013 admitted 107 cases of pediatric asthmatic bronchitis patients. The 107 cases of asthmatic bronchitis in children with clinical data were retrospectively analyzed. All patients were divided into experimental group and control group according to different methods of medication. In the experimental group, 55 cases were given salbutamol and budesonide on the basis of routine treatment. The control group, 52 cases only applied routine treatment. To compare the therapeutic effects, the clinical symptoms (cough, shortness of breath, the pulmonary rales) disappearance time and the incidence of adverse reactions in the two groups of asthmatic bronchitis patients, to investigate the effects of the conventional treatment with nebulized inhalation Salbutamol and budesonide in children with asthma bronchopneumonia. Results: In the conventional method, the effective rate of inhalation of budesonide and albuterol in the experimental group was as high as that in the control group, but there was significant difference between the two groups (P <0.05). The disappearance time of clinical features of the experimental group was significantly less than that of the control group (P <0.05). The adverse reaction rate of asthmatic bronchitis in experimental group was significantly lower than that in control group (P <0.05). Conclusions: Salbutamol and budesonide are effective adjuvant treatment of asthmatic bronchitis in children with asthma bronchitis, significantly improve the efficiency of treatment, and accelerate the disappearance of symptoms such as cough, shortness of breath and pulmonary rales, without significantly increasing the rate of adverse reactions, which is worthy of clinical promotion use.